Unlike PCR methods, no extraction step is required prior to analysis. On March 26, 2020, the FDA named 29 entities that duly notified the agency and therefore can now distribute their tests antibody screening.
Tofauti na mbinu za PCR hatua za uchukuaji haihitajiki kabla ya jaribio.Tarehe 26 Machi, 2020, FDA ilitoa majina ya mashirika 29 zilizotoa taarifa kwa shirika hilo inavyohitajika na kwa hivyo kwa sasa yana uwezo wa kusambaza vipimo vyao vya antibodi.